Mutations in the genes for presenilin 1 and 2 (PS-1 and PS-2) have been linked to development of early-onset Alzheimer's disease (AD). As neither the normal function of either presenilin is known nor why mutations cause disease, we examined the properties of wild-type, truncated, and mutant PS-2 upon expression in HeLa cells. Although HeLa cells are strongly predisposed to continued mitosis, expression of PS-2 induced programmed cell death (apoptosis). Direct evidence for apoptosis was obtained by double staining for terminal deoxynucleotide transferase nick end labeling (TUNEL) and PS-2 expression and by following green fluorescent protein–tagged PS-2 over time. Deletion analysis indicates that as little as 166 NH2-terminal residues of PS-2 are sufficient for endoplasmic reticulum (ER) localization and apoptosis. Moreover, the AD- associated PS-2 missense mutation (N141I) more efficiently induced cell death compared to wild-type PS-2 despite lower mutant protein accumulation. Expression of the presenilins in several other cell lines and transgenic mice has been accompanied by rapid protein cleavage without the induction of cell death. In contrast, PS-2 expressed in HeLa cells was not cleaved, and cell death occurred. We hypothesize that full-length but not cleaved PS-2 may be important in the regulation or induction of apoptosis.
Skip Nav Destination
Article navigation
20 October 1997
Article|
October 20 1997
Increased Apoptosis Arising from Increased Expression of the Alzheimer's Disease–associated Presenilin-2 Mutation (N141I)
Susan Janicki,
Susan Janicki
Medical Biotechnology Center of the University of Maryland Biotechnology Institute and Departments of Molecular Biology and Biophysics, Neurology, and Human Genetics, Baltimore, Maryland 21201
Search for other works by this author on:
Mervyn J. Monteiro
Mervyn J. Monteiro
Medical Biotechnology Center of the University of Maryland Biotechnology Institute and Departments of Molecular Biology and Biophysics, Neurology, and Human Genetics, Baltimore, Maryland 21201
Search for other works by this author on:
Susan Janicki
Medical Biotechnology Center of the University of Maryland Biotechnology Institute and Departments of Molecular Biology and Biophysics, Neurology, and Human Genetics, Baltimore, Maryland 21201
Mervyn J. Monteiro
Medical Biotechnology Center of the University of Maryland Biotechnology Institute and Departments of Molecular Biology and Biophysics, Neurology, and Human Genetics, Baltimore, Maryland 21201
Address all correspondence to Mervyn J. Monteiro, Ph.D., University of Maryland Biotechnology Institute, Room N352, 725 West Lombard Street, Baltimore, MD 21201. Tel.: (410) 706-8132. Fax: (410) 706-1732.
Received:
April 28 1997
Revision Received:
August 19 1997
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1997
J Cell Biol (1997) 139 (2): 485–495.
Article history
Received:
April 28 1997
Revision Received:
August 19 1997
Citation
Susan Janicki, Mervyn J. Monteiro; Increased Apoptosis Arising from Increased Expression of the Alzheimer's Disease–associated Presenilin-2 Mutation (N141I) . J Cell Biol 20 October 1997; 139 (2): 485–495. doi: https://doi.org/10.1083/jcb.139.2.485
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement